Clinical trial Recruiting at 3 sites Phase 3 Interventional Ages 2 to 17

Evaluating ferumoxytol for treating iron deficiency anemia in children

Official title: A Phase 3, Randomized, Open-Label, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects

Run by AMAG Pharmaceuticals, Inc. · NCT03893045 · Data updated 2026-11-12

This study is testing if a new iron treatment called ferumoxytol works better than the usual iron sucrose for kids with iron deficiency anemia.

More Iron Deficiency Anemia trials

Quick facts

PhasePhase 3
Study typeInterventional
Ages2 Years to 17 Years
SexAll
Enrollment75 (estimated)
SponsorAMAG Pharmaceuticals, Inc.
Industry-sponsored
Locations15 sites (Little Rock, Arkansas and 14 other locations)
StatusRecruiting
StartedSeptember 18, 2019
Main results expectedJuly 2026
Study endsOctober 2026
Registry record updatedApril 17, 2026
Trial IDNCT03893045 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are pediatric patients aged 2 to less than 18 years diagnosed with iron deficiency anemia who have not responded well to oral iron therapy.

Probably not a fit

Patients with chronic kidney disease or those who have a known hypersensitivity to ferumoxytol or iron sucrose may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 3, randomized, open-label study involves pediatric subjects aged 2 to less than 18 years with iron deficiency anemia (IDA). Participants will be randomly assigned to receive either ferumoxytol or iron sucrose, with treatment regimens designed to assess the efficacy and safety of these interventions. The study will monitor hemoglobin levels and adverse events over a period of five weeks following treatment. The aim is to determine the effectiveness of ferumoxytol compared to traditional iron sucrose therapy in this population.

Why it matters

Potential benefit: If successful, this study could provide a more effective treatment option for children suffering from iron deficiency anemia.

How similar studies have gone: Other studies have shown promising results with ferumoxytol in treating iron deficiency anemia, indicating a potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Male or female 2 years to \<18 years of age at time of consent
2. Has IDA defined as:

   1. Hemoglobin (Hgb) \<11.0 g/dL AND
   2. Any one or more of the following:

      * Transferrin saturation (TSAT) \<20%
      * ferritin \<100 ng/mL
3. Documented history of unsatisfactory oral iron therapy or in whom oral iron cannot be tolerated, or for whom oral iron is considered medically inappropriate

Exclusion Criteria:

1. Known hypersensitivity reaction to any component of ferumoxytol or iron sucrose
2. History of allergy to intravenous (IV) iron
3. History of ≥2 clinically significant drug allergies
4. Subjects with CKD (defined as eGFR of \<60 mL/min/1.73 m2 or a requirement for chronic hemodialysis or peritoneal dialysis during Screening)
5. Low systolic blood pressure (BP) (age 1 to 9 years \<70 + \[age in years x 2\] mmHg, age 10 to 17 years \<90 mmHg)
6. Hgb ≤7.0 g/dL
7. Serum ferritin level \>600 ng/mL

Where it's running

  • Optimus U Corporation
    Miami, Florida, United States
    Recruiting
  • Biomedical Research LLC
    Miami, Florida, United States
    Recruiting
  • Sun Research Institute
    San Antonio, Texas, United States
    Recruiting
  • Arkansas Children's Hospital
    Little Rock, Arkansas, United States
    Not yet recruiting
  • University of Florida
    Gainesville, Florida, United States
    Not yet recruiting
  • Gwinnett Research Institute
    Buford, Georgia, United States
    Not yet recruiting
Show 9 more locations
  • JSC Saules seimos medicinos centras
    Kaunas, Lithuania
    Not yet recruiting
  • Klaipeda Children's Hospital
    Klaipėda, Lithuania
    Not yet recruiting
  • Children's Hospital-Affiliate of Vilnius University Hospital Santariskiu Klinikos
    Vilnius, Lithuania
    Not yet recruiting
  • Osrodek Badan Klinicznych In Vivo sp. z o.o.
    Bydgoszcz, Poland
    Not yet recruiting
  • Prywatny Gabinet Lekarski Dr N. med. Jerzy Brzostek
    Dębica, Poland
    Not yet recruiting
  • Pro Familia Altera Sp. z o.o.
    Katowice, Poland
    Not yet recruiting
  • Korczowski Bartosz, Gabinet Lekarski
    Rzeszów, Poland
    Not yet recruiting
  • Centrum Zdrowia MDM
    Warsaw, Poland
    Not yet recruiting
  • Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu
    Wroclaw, Poland
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.